2018
DOI: 10.1146/annurev-bioeng-062117-120947
|View full text |Cite
|
Sign up to set email alerts
|

Circulating Tumor Cells: Diagnostic and Therapeutic Applications

Abstract: Metastasis contributes to poor prognosis in many types of cancer and is the leading cause of cancer-related deaths. Tumor cells metastasize to distant sites via the circulatory and lymphatic systems. In this review, we discuss the potential of circulating tumor cells for diagnosis and describe the experimental therapeutics that aim to target these disseminating cancer cells. We discuss the advantages and limitations of such strategies and how they may lead to the development of the next generation of antimetas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
68
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 86 publications
(68 citation statements)
references
References 146 publications
0
68
0
Order By: Relevance
“…Metastasis is a common cause of death in patients with colorectal cancer (CRC) [1]. Moreover, circulating tumour cells (CTCs) are closely related to tumour metastasis and have become an important biomarker in predicting recurrence and mortality [2]. CTCs survival, and the subsequent adhesion, extravasation, and colonisation of these cells are critical determinants of tumour metastasis [3].…”
Section: Introductionmentioning
confidence: 99%
“…Metastasis is a common cause of death in patients with colorectal cancer (CRC) [1]. Moreover, circulating tumour cells (CTCs) are closely related to tumour metastasis and have become an important biomarker in predicting recurrence and mortality [2]. CTCs survival, and the subsequent adhesion, extravasation, and colonisation of these cells are critical determinants of tumour metastasis [3].…”
Section: Introductionmentioning
confidence: 99%
“…During metastasis formation, the overall natural killer (NK) cell count is increased. CTCs can modulate NK cell anti-tumor activity through production of inhibitory cytokines (e.g., IL-1β, IL-8, IL-10, and prostaglandin E2) that block the NK cell immunoglobulin receptors (KIRs) [2,3] (Figure 3a). Toll-like receptors (TLRs), which are expressed on macrophages and dendritic cells (DCs), can activate NK cell cytolytic killing [67].…”
Section: Ctcs Escape the Innate Immune System Responsementioning
confidence: 99%
“…Finally, hypoxia stress signals ensure CTC survival through activation of autophagy to provide the nutrients (e.g., amino acid, ATP, fatty acid) required for cell metabolism [27]. Immune cells express TNF-related apoptosis-inducing ligand (TRAIL) that binds to the tumor cell membrane death receptors 4/5 (DR4/5) and induces the extrinsic caspase-dependent apoptosis signaling pathway in tumor cells [3,100]. However, autophagy induces DR4/5 endocytosis on CTCs surface, resulting in their degradation and resistance to TRAIL-mediated apoptosis [27].…”
Section: Ctcs Induce Resistance To Chemotherapymentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, the enrichment and viable CTCs culture from blood of cancer patients will create many opportunities for the development of new anti-cancer drugs for Future therapeutic goals [13]. Isolation and cell counting are also required to monitor post-treatment in many types of cancer therapy [14].…”
Section: Introductionmentioning
confidence: 99%